Candel Therapeutics (CADL) EPS (Diluted) (2021 - 2025)

Candel Therapeutics (CADL) EPS (Diluted) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 0.00
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 0.00
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 6.75
7 Belite Bio 61.40 Bn 61.40 Bn - 0.00
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn 5.52
9 Revolution Medicines 37.37 Bn 37.37 Bn - -2.29
10 Candel Therapeutics 504.70 Mn 504.70 Mn - -0.29

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.29
Sep 30, 2025 -0.43
Jun 30, 2025 -0.42
Mar 31, 2025 -0.38
Dec 31, 2024 -0.25
Sep 30, 2024 -0.90
Jun 30, 2024 -0.86
Mar 31, 2024 -0.28
Dec 31, 2023 -0.36
Sep 30, 2023 -0.33
Jun 30, 2023 -0.68
Mar 31, 2023 -0.35
Dec 31, 2022 -0.30
Sep 30, 2022 -0.31
Jun 30, 2022 -0.32
Mar 31, 2022 -1.33
Dec 31, 2021 -1.38
Sep 30, 2021 -0.34
Jun 30, 2021 -0.45